KRT8 and small cell lung carcinoma: Targeted radiotherapy with177Lu-DOTA-Tyr3-octreotate might further increase the cytoplasmic release of K8 and thereby increase the accumulation of radiolabelled TS1 antibodies in SCLC tumours.